End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.85 CNY | +4.10% | +14.52% | +15.00% |
30/04 | Guizhou Chanhen Chemical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
22/04 | Guizhou Chanhen Chemical's Capital to Decline After Restricted Share Buyback | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- With a P/E ratio at 12.7 for the current year and 9.24 for next year, earnings multiples are highly attractive compared with competitors.
- This company will be of major interest to investors in search of a high dividend stock.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.00% | 1.63B | - | ||
+5.69% | 104B | A- | ||
-3.35% | 64.55B | A- | ||
+46.67% | 41.5B | B | ||
+19.71% | 40.01B | B | ||
+6.70% | 33.03B | A- | ||
+11.78% | 20.11B | B- | ||
+17.06% | 17.52B | C+ | ||
+20.73% | 15.51B | B- | ||
+11.69% | 15.34B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 002895 Stock
- Ratings Guizhou Chanhen Chemical Corporation